Grade: D — Significant Concerns
Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles
Data: SEC EDGAR 10-K (Filed 2026-02-12, FY ended December 31, 2025) + Yahoo Finance
Auditor: PricewaterhouseCoopers LLP — Unqualified opinion (1 critical audit matter: revenue recognition)
One-line verdict: Corteva's earnings quality is mechanically adequate — CFFO/NI of 3.11 and FCF/NI of 2.57 are exceptional, and the M-Score is clean at -2.75 — but the balance sheet carries $18.8B in goodwill plus intangibles (78% of equity), an artifact of the DowDuPont merger's acquisition accounting. Meanwhile, the company has announced plans to separate its Seed and Crop Protection businesses into two standalone public companies, which introduces significant execution risk and potential impairment exposure on goodwill that was allocated based on the combined entity's value. AR has outpaced revenue for two consecutive years, coinciding with extended farmer credit terms in a challenging agricultural market.
| Metric | Result |
|---|---|
| Red Flags | **2** (AR trend, goodwill/equity) |
| Watch Items | **0** |
| Checks Completed | **17/18** (1 N/A: impairment data) |
| Beneish M-Score | **-2.75** (clean) |
| Z-Score | **2.46** (grey zone) |
| Auditor | PricewaterhouseCoopers LLP |
Two Businesses, One Company — For Now
Per the filing: "On October 1, 2025, the company announced its intent to separate its Seed and Crop Protection businesses into two standalone, publicly traded companies." Corteva operates through two segments:
| Segment | FY2025 Net Sales | FY2024 Net Sales | Change |
|---|---|---|---|
| Seed | ~$9.8B* | ~$9.3B* | +5.4% |
| Crop Protection | ~$7.6B* | ~$7.6B* | Flat |
| Total | $17,401M | $16,908M | +2.9% |
The Seed segment "develops and supplies commercial seed combining superior germplasm with advanced traits to produce high yield potential for farmers around the world." Crop Protection "supplies products to protect crop yields against weeds, insects and disease." Key brands include Pioneer seeds, Brevant seeds, and PhytoGen cottonseed.
Profitability: Slowly Recovering
| Metric | FY2023 | FY2024 | FY2025 | Trend |
|---|---|---|---|---|
| Revenue | $17,226M | $16,908M | $17,401M | Essentially flat over 3 years |
| Net Income | $735M | $907M | $1,094M | +49% over 3 years |
| Gross Margin | 42.4% | 43.6% | 47.3% | Expanding 3 consecutive years |
| EPS (diluted, continuing) | $1.31 | $1.23 | $1.75 | Volatile |
| Net Margin | 4.3% | 5.4% | 6.3% | Improving but thin |
Per the filing: "Net income (loss) attributable to Corteva" was $1,094 million, $907 million, and $735 million for FY2025, FY2024, and FY2023 respectively. The improvement is driven by gross margin expansion from 42.4% to 47.3% — a meaningful 490 basis point gain. The filing attributes this to lower commodity costs and favorable product mix, partially offset by "lower planted area."
However, net margin of 6.3% on $17.4B revenue is thin for a company carrying $18.8B in intangible assets. ROE of 4.5% is extremely low, reflecting the bloated equity denominator from merger accounting.
Cash Flow: The Saving Grace
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating Cash Flow | $1,769M | $2,145M | $3,406M |
| Net Income | $735M | $907M | $1,094M |
| CFFO / NI | 2.41 | 2.36 | 3.11 |
| CapEx | $595M | $597M | $591M |
| Free Cash Flow | $1,174M | $1,548M | $2,815M |
CFFO/NI of 3.11 and FCF/NI of 2.57 are exceptionally strong. The large gap between net income and operating cash flow reflects substantial depreciation and amortization of the intangible assets from the DowDuPont merger — real cash is flowing into the business far more than reported earnings suggest. Per the filing, operating cash flow improvement was driven by "favorable changes in customer prepayments and collections, and favorable changes in accounts payable."
The company returned capital to shareholders through buybacks ($756M in FY2023) and a dividend of $0.18/quarter (increased 6% from $0.17).
The 18-Point Screening
Revenue Quality
| # | Check | Result | Detail |
|---|---|---|---|
| A1 | DSO Change | ✅ | DSO 106 days, +6 days YoY |
| A2 | AR vs Revenue Growth | ❌ | AR outpaced revenue for 2 consecutive years |
| A3 | Revenue vs CFFO | ✅ | Revenue +2.9%, CFFO +58.8% |
A2 — AR growing faster than revenue. Accounts receivable (trade) increased to $4,881M from $4,448M (+9.7%) while revenue grew only 2.9%. The filing shows allowances for doubtful accounts increased from $179M to $241M — a 35% jump that suggests the company is extending credit more aggressively. DSO of 106 days is high for any industry and reflects Corteva's agricultural business cycle where farmers purchase seed on credit before harvest. But the trend is deteriorating.
Expense Quality
| # | Check | Result | Detail |
|---|---|---|---|
| B1 | Inventory vs COGS | ✅ | Inventory +4.3% vs COGS -3.7% |
| B2 | CapEx vs Revenue | ✅ | CapEx growth -1.0% vs revenue +2.9% |
| B3 | SG&A Ratio | ✅ | SG&A/Gross Profit = 42.4%. Normal |
| B4 | Gross Margin | ✅ | 47.3%, +3.6pp expansion |
Cash Flow Quality
| # | Check | Result | Detail |
|---|---|---|---|
| C1 | CFFO vs Net Income | ✅ | CFFO/NI = 3.11. Exceptional |
| C2 | Free Cash Flow | ✅ | FCF $2.8B, FCF/NI = 2.57 |
| C3 | Accruals Ratio | ✅ | -5.4%. Negative accruals — clean |
| C4 | Cash vs Debt | ✅ | Cash $4.5B covers debt $2.6B |
Cash position is strong — $4.5B cash against only $2.6B debt, with $6.2B total liquidity. This is one of the few companies in this batch with positive net cash.
Balance Sheet
| # | Check | Result | Detail |
|---|---|---|---|
| D1 | Goodwill + Intangibles | ❌ | $18.8B = 78% of equity |
| D2 | Leverage | ✅ | Debt/EBITDA = 0.8x. Very healthy |
| D3 | Soft Asset Growth | ✅ | Other assets +12.9% vs revenue +2.9% |
| D4 | Asset Impairment | — | No write-off data available |
D1 — Merger-legacy goodwill dominates the balance sheet. Goodwill of $10,465M and other intangible assets of $8,301M together total $18.8B — 78% of total equity. This is not from aggressive recent acquisitions but from the 2019 spin-off from DowDuPont. The intangible assets are amortizing (declined from $8,876M to $8,301M YoY), but the goodwill is static and subject to impairment risk if the planned separation reduces the fair value of either standalone entity below its allocated goodwill carrying amount.
Acquisition Risk
| # | Check | Result | Detail |
|---|---|---|---|
| E1 | Serial Acquirer FCF | ✅ | FCF after acquisitions positive |
| E2 | Goodwill Surge | ✅ | Goodwill change -3% YoY |
Manipulation Score
| # | Check | Result | Detail |
|---|---|---|---|
| F1 | Beneish M-Score | ✅ | -2.75 (clean) |
Key Risks from the 10-K
1. Planned Separation Creates Impairment and Execution Risk
The announced separation into two public companies requires goodwill to be reallocated between Seed and Crop Protection. If either standalone entity's fair value falls below its allocated goodwill, an impairment charge could be material. The filing warns: "Executing the proposed separation will require significant amounts of time and effort."
2. PFAS Environmental Liability
Corteva inherited PFAS-related environmental liabilities from the DowDuPont merger. The filing references ongoing obligations shared with DuPont and Chemours, with maximum exposure subject to memoranda of understanding. PFAS litigation and remediation costs are escalating industry-wide.
3. Agricultural Market Cyclicality and Climate Risk
The filing warns that "climate change may increase the frequency or intensity of extreme weather such as storms, floods, heat waves, droughts and other events that could affect the quality, volume and cost of seed produced." Revenue has been essentially flat at $17B for three years despite margin improvement.
4. Revenue Recognition Complexity — The Auditor's Critical Audit Matter
PwC identified revenue recognition from product sales as the critical audit matter, reflecting the complexity of Corteva's global seed and crop protection contracts with their variable pricing, return provisions, and seasonal rebates.
Summary
Grade: D. Legacy goodwill at 78% of equity creates impairment risk that is heightened by the announced Seed/Crop Protection separation — despite excellent cash flow quality.
Corteva is a paradox: exceptional cash flow (CFFO/NI of 3.11, FCF/NI of 2.57), nearly zero leverage (Debt/EBITDA 0.8x), net cash position ($4.5B vs. $2.6B debt), and a clean M-Score — yet the balance sheet is dominated by $18.8B in intangible assets from a merger completed six years ago. The D grade reflects two red flags: the goodwill concentration and the AR trend. The planned separation is the critical variable — it could unlock value if executed well, or trigger impairment charges if the standalone entities cannot support their allocated goodwill.
**Disclaimer**: This report is based on Corteva's FY2025 10-K filed with SEC EDGAR on February 12, 2026. This is NOT investment advice.
Data: SEC EDGAR 10-K + Yahoo Finance
Auditor: PricewaterhouseCoopers LLP (Unqualified opinion, 1 critical audit matter — revenue recognition)
Fiscal year ended: December 31, 2025